and a novel small molecule inhibiting PTPN1/2 at the American Association for Cancer Research (AACR) Annual The consensus price target hints at a 212.5% upside potential for iTeos Therapeutics (ITOS).

and a novel small molecule inhibiting PTPN1/2 at the American Association for Cancer Research (AACR) Annual WATERTOWN, Mass. and GOSSELIES, Belgium, Jan. 08, 2025 (GLOBE NEWSWIRE) -- iTeos ...

Time frame: 1 March 2024 - 28 February 2025 Institution search supports local language names. (Examples: Universidad Autónoma de Madrid, 筑波大学) View the latest institution tables ...

Qingdao Key Laboratory of Biomacromolecular Drug Discovery and Development, College of Chemical Engineering, Qingdao University of Science and Technology, Qingdao 266042, China School of Medicine and ...

Proteolysis targeting chimera (PROTAC) technology has emerged as a powerful tool in drug discovery that enables targeted protein degradation through a unique bifunctional approach. This review ...

Guangdong Key Laboratory of Chiral Molecule and Drug Discovery, School of Pharmaceutical Sciences, Sun Yat-sen University, Guangzhou 510006, China State Key Laboratory of Anti-Infective Drug Discovery ...

The endocrine functions exerted by ovarian granulosa cells (GCs) are crucial factors in maintaining follicle development, as oocyte development relies on providing energy substrates and cytokines by ...

Introduction: Bladder cancer shows distinct sex-related patterns, with male patients experiencing significantly higher incidence and female patients facing poorer survival outcomes. This study aimed ...

Objective: To discuss the recent literature on paternal obesity, focusing on the possible mechanisms of transmission of the phenotypes from the father to the children. Sources: A non-systematic review ...

T cell protein tyrosine phosphatase (TC-PTP; also known as PTPN2) and protein tyrosine phosphatase 1B (PTP-1B; also known as PTPN1) are intracellular phosphatases with a high degree of sequence and ...